DIN 02324784 — SIMPONI 50 MG
SIMPONI is a solution of Golimumab marketed by JANSSEN INC. The full Golimumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02324784
- Brand name
- SIMPONI
- Active ingredient
- Golimumab
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Tumour necrosis factor alpha (TNFα) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Golimumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02413175 | SIMPONI | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02413183 | SIMPONI | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02324776 | SIMPONI | 50 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02417472 | SIMPONI I.V. | 50 MG | SOLUTION | JANSSEN INC | MARKETED |